Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway

British Journal of Haematology

Volumn 139, Issue 3, 2007, Pages 494-503

  Lovely, Rehana S ^a   Boshkov, Lynn K ^a   Marzec, Ulla M ^b   Hanson, Stephen R ^b   Farrell, David H ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

Animal model; Anticoagulants; Blood coagulation; Factor VIII; Thrombin; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRINOGEN; THROMBIN; ANTICOAGULANT AGENT; FIBRINOPEPTIDES GAMMA; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRIN CLOT; MALE; NONHUMAN; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOPLASTIN TIME; THROMBOSIS; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PAPIO; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIII; FIBRINOGEN; MALE; PAPIO; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; PROTHROMBIN TIME; THROMBIN; THROMBOSIS;

EID: 34848841484     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06825.x     Document Type: Article

References (64)

1. Baglia, F.A., Shrimpton, C.N., Emsley, J., Kitagawa, K., Ruggeri, Z.M., Lopez, J.A. Walsh, P.N. (2004) Factor XI interacts with the leucine-rich repeats of glycoprotein Ibα on the activated platelet. Journal of Biological Chemistry, 279, 49323 49329.
2. Bock, L.C., Griffin, L.C., Latham, J.A., Vermaas, E.H. Toole, J.J. (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature, 355, 564 566.
3. Bode, C., Mehwald, P., Schmedtje, M.P.H., Harker, L.A., Hudelmayer, M., Haber, E., Hanson, S.R. Runge, M.S. (1997) The antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. Circulation, 95, 800 804.
4. de Bosch, N.B., Mosesson, M.W., Ruiz-Saez, A., Echenagucia, M. Rodriguez-Lemoin, A. (2002) Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thrombosis and Haemostasis, 88, 253 258.
5. Cadroy, Y. Hanson, S.R. (1990) Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model. Blood, 75, 2185 2193.
6. Cadroy, Y., Houghton, R.A. Hanson, S.R. (1989) RGDV peptide selectivity inhibits platelet dependent thrombus formation in vivo. Journal of Clinical Investigation, 84, 939 944.
7. Castro, H.C., Monteiro, R.Q., Assafim, M., Loureiro, N.I., Craik, C. Zingali, R.B. (2006) Ecotin modulates thrombin activity through exosite-2 interactions. International Journal of Biochemistry and Cell Biology, 38, 1893 1900.
8. Celikel, R., McClintock, R.A., Roberts, J.R., Mendolicchio, G.L., Ware, J., Varughese, K.I. Ruggeri, Z.M. (2003) Modulation of α-thrombin function by distinct interactions with platelet glycoprotein Ibα. Science, 301, 218 221.
9. Chung, D.W. Davie, E.W. (1984) γ and γ′ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry, 23, 4232 4236.
10. Collet, J.P., Nagaswami, C., Farrell, D.H, Montalescot, G. Weisel, J.W. (2004) Influence of γ′ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 382 386.
11. De Candia, E., Hall, S.W., Rutella, S., Landolfi, R., Andrews, R.K. De Cristofaro, R. (2001) Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. Journal of Biological Chemistry, 276, 4692 4698.
12. De Cristofaro, R. De Filippis, V. (2003) Interaction of the 268-282 region of glycoprotein Ibα with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. Biochemical Journal, 373, 593 601.
13. De Cristofaro, R., De Candia, E., Rutella, S. Weitz, J.I. (2000) The Asp(272)-Glu(282) region of platelet glycoprotein Ibα interacts with the heparin-binding site of α-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. Journal of Biological Chemistry, 275, 3887 3895.
14. Dumas, J.J., Kumar, R., Seehra, J., Somers, W.S. Mosyak, L. (2003) Crystal structure of the GpIbα-thrombin complex essential for platelet aggregation. Science, 301, 222 226.
15. Esmon, C.T. Lollar, P. (1996) Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. Journal of Biological Chemistry, 271, 13882 13887.
16. Fallon, A.M., Shah, N., Marzec, U.M., Warnock, J.N., Yoganathan, A.P. Hanson, S.R. (2006) Flow and thrombosis at orifices simulating mechanical heart valve leakage regions. Journal of Biomechancial Engineering, 128, 30 39.
17. Falls, L.A. Farrell, D.H. (1997) Resistance of γA/γ′ fibrin clots to fibrinolysis. Journal of Biological Chemistry, 272, 14251 14256.
18. Farrell, D.H. (2004) Pathophysiologic roles of the fibrinogen γ chain. Current Opinion in Hematology, 11, 151 155.
19. Farrell, D.H., Thiagarajan, P., Chung, D.W. Davie, E.W. (1992) Role of fibrinogen α and γ chain sites in platelet aggregation. Proceedings of the National Academy of Sciences of the United States of America, 89, 10729 10732.
20. Fornace, A.J., Cummings, D.E., Comeau, C.M., Kant, J.A. Crabtree, G.R. (1984) Structure of the human γ-fibrinogen gene: alternate mRNA splicing near the 3' end of the gene produces γA and γB forms of γ-fibrinogen. Journal of Biological Chemistry, 259, 12826 12830.
21. Furie, B. Furie, B.C. (2006) Thrombus formation in a living mouse. Pathophysiology of Haemostasis and Thrombosis, 35, 1 4.
22. Gailani, D. Broze, Jr., G.J. (1991) Factor XI activation in a revised model of blood coagulation. Science, 253, 909 912.
23. Gruber, A., Harker, L.A., Hanson, S.R. Griffin, J.G. (1991) Antithrombotic effects of combining activated protein C with urokinase in primates. Circulation, 84, 2454 2462.
24. Haidaris, P.J. Courtney, M.A. (1992) Liver-specific RNA processing of the ubiquitously transcribed rat fibrinogen γ-chain gene. Blood, 79, 1218 1224.
25. 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin. Blood, 74, 2437 2444.
26. Hanson, S.R. Harker, L.A. (1987) Baboon models of acute arterial thrombosis. Thrombosis and Haemostasis, 58, 801 805.
27. Hanson, S.R., Kotze, H.F., Savage, B. Harker, L.A. (1985) Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis, 5, 595 603.
28. Hanson, S.R., Griffin, J.H., Harker, L.A., Kelly, A.B., Esmon, C.T. Gruber, A. (1993) Antithrombotic effects of thrombin-induced activaton of endogenous Protein C in primates. Journal of Clinical Investigation, 92, 2003 2012.
29. Harker, L.A., Marzec, U.M., Kelly, A.B., Chronos, N.A.F., Sundell, I.B., Hanson, S.R. Herbert, J.-M. (1998) Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation, 98, 2461 2469.
30. Henschen, A.H. (1993) Human fibrinogen-structural variants and functional sites. Thrombosis and Haemostasis, 70, 42 47.
31. Hogg, P.J. Jackson, C.M. (1989) Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III, implications for heparin therapy. Proceedings of the National Academy of Sciences of the United States of America, 86, 3619 3623.
32. Kaczmarek, E. McDonagh, J. (1988) Thrombin binding to the Aα-, Bβ-, and γ-chains of fibrinogen and to their remnants contained in fragment E. Journal of Biological Chemistry, 263, 13896 13900.
33. Kazal, L.A., Amsel, S., Miller, O.P. Tocantins, L.M. (1963) The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proceedings of the Society for Experimental Biology and Medicine, 113, 989 994.
34. Kelly, A.B., Marzec, U.M., Krupski, W., Bass, A., Cadroy, Y., Hanson, S.R. Harker, L.A. (1991) Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood, 77, 1006 1012.
35. Kirschbaum, N.E., Mosesson, M.W. Amrani, D.L. (1992) Characterization of the γ chain platelet binding site on fibrinogen fragment D. Blood, 79, 2643 2648.
36. Kumar, R., Beguin, S. Hemker, H.C. (1994) The influence of fibrinogen and fibrin on thrombin generation-evidence for feedback activation of the clotting system by clot bound thrombin. Thrombosis and Haemostasis, 72, 713 721.
37. Legrele, C.D., Wolfenstein-Todel, C., Hurbourg, Y. Mosesson, M.W. (1982) Evidence for two classes of rat plasma fibrinogen gamma chains differing by their COOH-terminal amino acid sequences. Biochemical and Biophysical Research Communications, 105, 521 529.
38. Liaw, P.C., Fredenburgh, J.C., Stafford, A.R., Tulinsky, A., Austin, R.C. Weitz, J.I. (1998) Localization of the thrombin-binding domain on prothrombin fragment 2. Journal of Biological Chemistry, 273, 8932 8939.
39. Lovely, R.S., Falls, L.A., Al-Mondhiry, H.A., Chambers, C.E., Sexton, G.J., Ni, H. Farrell, D.H. (2002) Association of γA/γ′ fibrinogen levels and coronary artery disease. Thrombosis and Haemostasis, 88, 26 31.
40. Lovely, R.S., Moaddel, M. Farrell, D.H. (2003) Fibrinogen γ′ chain binds thrombin exosite II. Journal of Thrombosis and Haemostasis, 1, 124 131.
41. Mann, K.G., Brummel-Ziedins, K., Orfeo, T. Butenas, S. (2006) Models of blood coagulation. Blood Cells, Molecules & Diseases, 36, 108 117.
42. Meh, D.A., Siebenlist, K.R. Mosesson, M.W. (1996) Identification and characterization of the thrombin binding sites on fibrin. Journal of Biological Chemistry, 271, 23121 23125.
43. Meh, D.A., Siebenlist, K.R., Brennan, S.O., Holyst, T. Mosesson, M.W. (2001) The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thrombosis and Haemostasis, 85, 470 474.
44. Moaddel, M., Farrell, D.H., Daugherty, M.A. Fried, M.G. (2000a) Interactions of human fibrinogens with factor XIII; roles of calcium and the γ′ peptide. Biochemistry, 39, 6698 6705.
45. Moaddel, M., Falls, L.A. Farrell, D.H. (2000b) The role of γA/γ′ fibrinogen in plasma factor XIII activation. Journal of Biological Chemistry, 275, 32135 32140.
46. Mosesson, M.W. (2003) Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thrombosis and Haemostasis, 89, 9 12.
47. Mosesson, M.W., Finlayson, J.S. Umfleet, R.A. (1972) Human fibrinogen heterogeneities. 3. Identification of chain variants. Journal of Biological Chemistry, 247, 5223 5227.
48. Naito, K. Fujikawa, K. (1991) Activation of human blood coagulation factor XI independent of factor XII. Journal of Biological Chemistry, 266, 7353 7358.
49. Pineda, A.O., Chen, Z.W., Marino, F., Mathews, F.S., Mosesson, M.W. Di Cera, E. (2007) Crystal structure of thrombin in complex with fibrinogen gamma' peptide. Biophysical Chemistry, 125, 556 559.
50. Pospisil, C.H., Stafford, A.R., Fredenburgh, J.C. Weitz, J.I. (2003) Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. Journal of Biological Chemistry, 278, 21584 21591.
51. Richardson, J.L., Fuentes-Prior, P., Sadler, J.E., Huber, R. Bode, W. (2002) Characterization of the residues involved in the human α-thrombin-haemadin complex: an exosite II-binding inhibitor. Biochemistry, 41, 2535 2542.
52. Runge, M.S., Harker, L.A., Bode, C., Ruef, J., Kelly, A., Marzec, U.M., Shaw, S., Haber, E. Hanson, S.R. (1996) Increased thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation, 94, 1412 1422.
53. Seegers, W.H., Nieft, M. Loomis, E.C. (1945) Note on the adsorption of thrombin on fibrin. Science, 101, 520 521.
54. Siebenlist, K.R., Meh, D.A. Mosesson, M.W. (1996) Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains. Biochemistry, 35, 10448 10453.
55. Siebenlist, K.R., Mosesson, M.W., Hernandez, I., Bush, L.A., Di Cera, E., Shainoff, J.R., Di Orio, J.P. Stojanovic, L. (2005) Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood, 106, 2730 2736.
56. Stone, S.R. Hofsteenge, J. (1986) Kinetics of the inhibition of thrombin by hirudin. Biochemistry, 25, 4622 4628.
57. Tasset, D.M., Kubik, M.F. Steiner, W. (1997) Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. Journal of Molecular Biology, 272, 688 698.
58. Warkentin, T.E. (2004) Bivalent direct thrombin inhibitors: hirudin and bivalirudin. Baillière's Best Practice & Research. Clinical Haematology, 17, 105 125.
59. Weiler, H. Isermann, B.H. (2003) Thrombomodulin. Journal of Thrombosis and Haemostasis, 1, 1515 1524.
60. Weisel, J.W. Nagaswami, C. (1992) Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophysical Journal, 63, 111 128.
61. Weitz, J.I. Linkins, L.A. (2007) Beyond heparin and warfarin: the new generation of anticoagulants. Expert Opinion on Investigational Drugs, 16, 271 282.
62. Weitz, J.I., Hudoba, M., Massel, D., Maraganore, J. Hirsh, J. (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Journal of Clinical Investigation, 86, 385 391.
63. Wolfenstein-Todel, C. Mosesson, M.W. (1980) Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal γ chain variant (γ′). Proceedings of the National Academy of Sciences of the United States of America, 77, 5069 5073.
64. Young, W.B., Mordenti, J., Torkelson, S., Shrader, W.D., Kolesnikov, A., Rai, R., Liu, L., Hu, H., Leahy, E.M., Green, M.J., Sprengeler, P.A., Katz, B., Yu, C., Janc, J.W., Elrod, K., Marzec, U.M. Hanson, S.R. (2006) Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, and efficacy in a baboon thrombosis model. Bioorganic & Medicinal Chemistry, 16, 2037 2041.